Neuropsychopharmacology
- Four dimensions of individualization in brain stimulation for psychiatric disorders: context, target, dose, and timing3 months ago
- Early-life adversity alters adult nucleus incertus neurons: implications for neuronal mechanisms of increased stress and compulsive behavior vulnerability4 months ago
- Central Med23 deficiency leads to malformation of dentate gyrus and ADHD-like behaviors in mice4 months ago
- Preregistered multi-site preclinical randomized controlled trials: the beginning of a new day in reverse translational science?4 months ago
- Grey matter morphometry in young adult e-cigarette users, tobacco cigarette users & non-using controls4 months ago
- Correction: Neuropsychopharmacology Volume 50 Issue 14 months ago
- The role of sex in the association between cannabis use disorder and resting-state functional connectivity4 months ago
Journal of Psychopharmacology
- A randomised double-blind, placebo-controlled trial of pramipexole in addition to mood stabilisers for patients with treatment-resistant bipolar depression (the PAX-BD study)6 months ago
- Associations between paraoxonase-1 activity and therapeutic drug monitoring indicators in schizophrenia patients treated with olanzapine: A cross-sectional study6 months ago
- Haloperidol dopamine receptor occupancy and antagonism correspond to delirium agitation scores and EPS risk: A PBPK-PD modeling analysis6 months ago
- Associations of treatment with hypnotics with suicide and attempted suicide: A nationwide cohort study6 months ago
- Brain serotonin, oxytocin, and their interaction: Relevance for eating disorders6 months ago
- Commentary: A framework for assessment of adverse events in psychedelic research6 months ago
- A reflection on paradigmatic tensions within the FDA advisory committee for MDMA-assisted therapy6 months ago
European Neuropsychopharmacology
- Efficacy, tolerability, and safety of xanomeline-trospium chloride for schizophrenia: A systematic review and meta-analysis6 months ago
- Interrelationships between polygenic risk scores, cognition, symptoms, and functioning in first-episode psychosis: A network analysis approach6 months ago
- Is creatine useful as adjuvant in cognitive-behavioural therapy for depression?6 months ago
- Genomic evidence of GLP-1 receptor as target for the treatment of substance use disorders7 months ago
- Opportunities to advance microRNA research in psychiatry7 months ago
- Respiratory health in serious mental illness7 months ago
- Contrasting genetic burden for bipolar disorder: Early onset versus late onset in an older adult bipolar disorder sample7 months ago